MannKind to Participate in Upcoming Investor Conferences

Rhea-AI Summary

MannKind (Nasdaq: MNKD) will participate in two investor conferences in Miami on March 10–11, 2026. CEO Michael Castagna, PharmD, and CFO Chris Prentiss will do fireside chats and 1x1 investor meetings.

Live audio webcasts and recorded sessions will be available on the company's investor website for about 90 days.

News Market Reaction – MNKD

+0.85%

1 alert

+0.85% News Effect

On the day this news was published, MNKD gained 0.85%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), announced today its attendance at two upcoming investor conferences, at which MannKind’s Chief Executive Officer, Michael Castagna, PharmD, and Chief Financial Officer, Chris Prentiss will participate in fireside chats and in 1x1 meetings with investors.

Leerink Partners 2026 Global Healthcare Conference in Miami
Tuesday, March 10, 3:40 p.m. ET

Barclays 28^th Annual Global Healthcare Conference in Miami
Wednesday, March 11, 1:00 p.m. ET

Links to the live audio webcast of the sessions will be available on MannKind Corporation’s website at: https://investors.mannkindcorp.com/events-and-presentations. Recorded versions will also be available on the website for approximately 90 days following the conference.

About MannKind
MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.

With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.

Learn more at mannkindcorp.com.

Contacts:
Investor Relations
Kate Miranda
(617) 921-5461
Email: ir@mnkd.com

Media Relations
Christie Iacangelo
(818) 292-3500
Email: media@mnkd.com

FAQ

When will MannKind (MNKD) present at the Leerink Partners 2026 Global Healthcare Conference?

MannKind will present on March 10, 2026 at 3:40 p.m. ET in Miami. According to the company, CEO Michael Castagna will participate in a fireside chat and 1x1 investor meetings during that session.

What is MannKind's (MNKD) schedule at the Barclays 28th Annual Global Healthcare Conference?

MannKind is scheduled for March 11, 2026 at 1:00 p.m. ET in Miami. According to the company, CFO Chris Prentiss will join the fireside chat and meet individually with investors that day.

Who from MannKind (MNKD) will participate in the March 2026 investor conference events?

MannKind's CEO Michael Castagna and CFO Chris Prentiss will participate in fireside chats and 1x1 investor meetings. According to the company, both executives will appear across the two Miami conference sessions.

How can investors access MannKind (MNKD) conference webcasts and recordings?

Investors can access live audio webcasts and recorded sessions via the company's investor website. According to the company, recordings will remain available on the site for approximately 90 days after the conferences.

Will MannKind (MNKD) offer recordings of the March 2026 conference presentations?

Yes, recorded versions will be available for approximately 90 days after the conferences. According to the company, recordings will be hosted on the investor website following each live audio webcast.

What topics will MannKind (MNKD) executives cover in the March 10–11, 2026 conference appearances?

Executives will participate in fireside chats and 1x1 investor meetings focused on corporate strategy and investor questions. According to the company, the sessions are intended for direct investor engagement rather than a formal product announcement.